• Home
  • Posts RSS
  • Comments RSS
  • Edit
Blue Orange Green Pink Purple

Experimental Drug Therapies

This blog is designed to cover the current controversy regarding experimental drug therapies. New drugs that are developed must go through a safety process. However, there are "compassionate use" exceptions made for seriously ill patients when no other treatments are effective. As future nurses/health-care workers, we need to be educated on this issue to be able to keep up with advancing medical science to be better advocates for our patients.

We hope that by reading this blog, we can provide you information on both sides of the issue so that you can form your own opinion on the topic. We also invite you to participate in our discussion by commenting on any of the posts!

Brief History of Experimental Drugs

Experimental drug therapy is something that has been apart of life, really ever since the beginning of time. Every culture has their history of medicine. For the Egyptians their extensive knowledge about the human anatomy from their mummification treatments gave them a great understanding of the body. They had a range of remedies, from using thyme as a pain reliever to using camphor for epilepsy. In Greece they used the stars for guides to how individual people will respond to different treatments. Today, at least in the US, the history and regulation of experimental drug therapy lies closely with that of the FDA’s (Food and Drug Administration) history.

The FDA was created as a way to protect consumers from the potential dangers in drugs and food. The FDA can trace its roots through Charles M. Wetherill of the Department of Agriculture who did studies on food, soils, and fertilizers. FDA got its start under the 1906 Pure Foods and Drug Act which prohibited interstate commerce in contaminated and misbranded food and drugs. In the 1930s FDA was given its current name and really started enforcing the regulation of food and drugs. In 1938, President Roosevelt signed the Federal Food, Drugs, and Cosmetic Act. This act gave new meaning for safe consumer goods and made it so that drug manufacturers had to provide scientific proof that their drugs and products were safe before they were allowed on the market.

President Kennedy signed the Drug Amendments of 1962, which stated that drug effectiveness had to be established prior to marketing or else it would not be truly safe. This required drug firms to send the adverse affects reports to the FDA. Also, any advertising in medical journals had to provide the doctor with all the possible risks and benefits.

The laws that were made in the past have shaped where we are today. These laws are beneficial to consumers, because they can have more assurance about taking a drug. But there are also problems with the laws. They often require so much time for an experimental drug to be tested that a lot of people are hurt because they have no way of accessing it.

By Stacie Guinn

Sources:

Fowler, R. (2007) Egytian Medical Treatments. Retrieved from http://egyptian-history.suite101.com/article.cfm/egyptian_medical_treatments

Jansen, W. (1981). The Story Behind the Labels. Retrieved from http://www.fda.gov/AboutFDA/WhatWeDo/History/Overviews/ucm056044.htm


Read More 4 comments | Posted by blogpharm edit post

4 comments

  1. Sue Guinn, RN on October 29, 2009

    There are many good things about the FDA. I think it is important to have truth in advertising and that drugs should be tested for safety. I just wish it didn't take so long to approve some treatments. I hope that with the new national health care they will take a look at this whole process.

     
  2. Anonymous on October 29, 2009

    I agree, that the FDA needs to work quick at approving many of the new drug out there. They also need to run many tests to prove they are safe for use. Look at the Swine flu shot, I don't understand how you are going to put an injection out for pick to get if you have not run clinically tests to see how safe it is. Running tests does not mean give out mass shot to the public and then see what side effects arise. How is that safe???

     
  3. Dave Hubbard on October 29, 2009

    You have to consider the downside to this also. If there is a quick path without doing everything needed to be as safe as possible then the there may be a way for a company to help speed the process along through some type of impropriety.
    At least under the current methods everyone has to go through basically the same process. Even so you still have drug companies not presenting complete information on their studies and the FDA is understaffed and can’t verify everything they are given. Consider the anti-inflammatory drug Celebrex. It was approved under this type of process, and when people started dying from its use it was discovered this had shown up in the testing but hadn’t been submitted to the FDA.

     
  4. Anonymous on October 29, 2009

    Everyone knows that most diseases are related to stress in one’s environment.

    Good natural Cannabis is well known to help relieve stress, resulting in less disease! It would at least be easy to get volunteers for a trial!

     


Post a Comment

Newer Post Older Post Home

UTA Pharmacology

  • Authors
      Max Flores, Stacie Guinn, Ryan Wencl
  • Links

    • Clinical Trials - Government
    • Society for Clinical Trials
    • Abilgail Alliance
    • Join a clinical trial
    • FDA

    Blog Archive

    • ▼  2009 (10)
      • ▼  October (10)
        • In Conclusion...
        • CBS News - H1N1 Experimental Drug
        • Considerations to experimental drug therapies
        • LIfe-threatening Drug Back on Market - Is it Worth...
        • Cancer Drug Not used to Fight Cancer?
        • Interview with an Experimental Drug Patient
        • “No seriously ill person should have to die merely...
        • How a Clinical Trial Works
        • Brief History of Experimental Drugs
        • Welcome!!!

    Experimental Drug Terminology


    CONTROL GROUP: The standard by which experimental observations are evaluated. In many clinical trials, one group of patients will be given an experimental drug or treatment, while the control group is given either a standard treatment for the illness or a placebo.

    DOUBLE-BLIND STUDY: A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study.

    DRUG-DRUG INTERACTION: A modification of the effect of a drug when administered with another drug. The effect may be an increase or a decrease in the action of either substance, or it may be an adverse effect that is not normally associated with either drug.

    EXPERIMENTAL DRUG: A drug that is not FDA licensed for use in humans, or as a treatment for a particular condition

    INFORMED CONSENT: The process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study.

    OFF-LABEL USE: A drug prescribed for conditions other than those approved by the FDA.

    PLACEBO: A placebo is an inactive pill, liquid, or powder that has no treatment value. In clinical trials, experimental treatments are often compared with placebos to assess the treatment's effectiveness

    PLACEBO EFFECT: A physical or emotional change, occurring after a substance is taken or administered, that is not the result of any special property of the substance. The change may be beneficial, reflecting the expectations of the participant and, often, the expectations of the person giving the substance.

    RANDOMIZATION:A method based on chance by which study participants are assigned to a treatment group. Randomization minimizes the differences among groups by equally distributing people with particular characteristics among all the trial arms. The researchers do not know which treatment is better. From what is known at the time, any one of the treatments chosen could be of benefit to the participan.

    SIDE EFFECTS:Any undesired actions or effects of a drug or treatment. Negative or adverse effects may include headache, nausea, hair loss, skin irritation, or other physical problems. Experimental drugs must be evaluated for both immediate and long-term side effects

    Other UTA Pharmacology Blogs

    • Prescription Drugs... In Our Drinking Water?
      Prescription drugs found in tap water 2009
      16 years ago
    • Nanobano's Blog
      Epilogue
      16 years ago
    • Do medications cause suicide ?
      The History of Antidepressants
      16 years ago
    • "Miracle" Weight Loss Pills
      Pros and Cons of Weight Loss Pills
      16 years ago
    • When You Can't Afford Your Medication
      In Conclusion
      16 years ago
    • Beta Blockers: Risks Versus Benefits
      A Note to our Audience
      16 years ago
    • Pharmacology in Nursing Practice
  • Search






    • Home
    • Posts RSS
    • Comments RSS
    • Edit

    © Copyright Experimental Drug Therapies. All rights reserved.
    Designed by FTL Wordpress Themes | Bloggerized by FalconHive.com
    brought to you by Smashing Magazine

    Back to Top